Jazz Pharmaceuticals Remains A Buy At Deutsche Bank Post Q2 Report By: Benzinga via Benzinga August 11, 2016 at 15:04 PM EDT Deutsche Bank maintained its Buy rating on Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ) despite the company's second ... Read More >> Related Stocks: Jazz Pharma Plc